LMI070 ( DrugBank: - )

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
3	脊髄性筋萎縮症	10
8	ハンチントン病	7

3. 脊髄性筋萎縮症

臨床試験数 : 217 / 薬物数 : 149 - (DrugBank : 33) / 標的遺伝子数 : 54 - 標的パスウェイ数 : 80

diseases per page:

Showing 1 to 10 of 10 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2014-002053-19-BG (EUCTR)	04/10/2018	31/07/2018	Clinical trial of LMI070 given by mouth to Type I SMA infant patients.	An open-label multi-part first-in-human study of oral LMI070in infants with Type 1 spinal muscular a ...	Spinal Muscular Atrophy MedDRA version: 20.1;Level: LLT;Classification code 10051203;Term: Spinal mu ...	Product Code: LMI070 INN or Proposed INN: Not established Other descriptive name: LMI070	Novartis Pharma Services AG	NULL	Not Recruiting			Female: yes Male: yes	44	Human pharmacology (Phase 1): yes Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - ...	United States;Hungary;Czech Republic;Poland;Belgium;Denmark;Russian Federation;Bulgaria;Netherlands; ...
2	EUCTR2014-002053-19-HU (EUCTR)	17/09/2018	17/07/2018	Clinical trial of LMI070 given by mouth to Type I SMA infant patients.	An open-label multi-part first-in-human study of oral LMI070in infants with Type 1 spinal muscular a ...	Spinal Muscular Atrophy MedDRA version: 20.1;Level: LLT;Classification code 10051203;Term: Spinal mu ...	Product Code: LMI070 Other descriptive name: LMI070	Novartis Pharma Services AG	NULL	Not Recruiting			Female: yes Male: yes	44	Human pharmacology (Phase 1): yes Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - ...	United States;Czech Republic;Hungary;Poland;Belgium;Denmark;Russian Federation;Bulgaria;Netherlands; ...
3	EUCTR2014-002053-19-CZ (EUCTR)	14/02/2018	30/10/2017	Clinical trial of LMI070 given by mouth to Type I SMA infant patients.	An open-label multi-part first-in-human study of oral LMI070in infants with Type 1 spinal muscular a ...	Spinal Muscular Atrophy MedDRA version: 20.1;Level: LLT;Classification code 10051203;Term: Spinal mu ...	Product Code: LMI070 INN or Proposed INN: Not established Other descriptive name: LMI070	Novartis Pharma Services AG	NULL	Not Recruiting			Female: yes Male: yes	44	Human pharmacology (Phase 1): yes Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - ...	United States;Hungary;Czech Republic;Poland;Belgium;Denmark;Bulgaria;Russian Federation;Netherlands; ...
4	NCT02268552 (ClinicalTrials.gov)	April 2, 2015	1/10/2014	An Open Label Study of LMI070 (Branaplam) in Type 1 Spinal Muscular Atrophy (SMA)	An Open Label Multi-part First-in-human Study of Oral LMI070in Infants With Type 1 Spinal Muscular A ...	Spinal Muscular Atrophy	Drug: branaplam	Novartis Pharmaceuticals	NULL	Active, not recruiting	N/A	182 Days	All	40	Phase 1/Phase 2	Belgium;Bulgaria;Denmark;Germany;Italy;Poland;Russian Federation;Czechia;Hungary;Netherlands
5	EUCTR2014-002053-19-IT (EUCTR)	01/04/2015	27/10/2014	Clinical trial of LMI070 given my mouth to Type I SMA infant patients.	An open-label multi-part first-in-human study of oral LMI070in infants with Type 1 spinal muscular a ...	Spinal Muscular Atrophy;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]	Product Name: NA Product Code: LMI070 INN or Proposed INN: NA Other descriptive name: NA	NOVARTIS FARMA S.p.A.	NULL	Not Recruiting			Female: yes Male: yes	22	Phase 1;Phase 2	United States;Hungary;Czech Republic;European Union;Poland;Belgium;Denmark;Bulgaria;Netherlands;Germ ...
6	EUCTR2014-002053-19-DE (EUCTR)	02/02/2015	30/10/2014	Clinical trial of LMI070 given by mouth to Type I SMA infant patients.	An open-label multi-part first-in-human study of oral LMI070in infants with Type 1 spinal muscular a ...	Spinal Muscular Atrophy MedDRA version: 20.1;Level: LLT;Classification code 10051203;Term: Spinal mu ...	Product Code: LMI070 INN or Proposed INN: Not established Other descriptive name: LMI070	Novartis Pharma Services AG	NULL	Not Recruiting			Female: yes Male: yes	44	Human pharmacology (Phase 1): yes Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - ...	Hungary;Czech Republic;Poland;Belgium;Denmark;Bulgaria;Netherlands;Germany;Italy
7	EUCTR2014-002053-19-DK (EUCTR)	16/12/2014	15/10/2014	Clinical trial of LMI070 given by mouth to Type I SMA infant patients.	An open-label multi-part first-in-human study of oral LMI070in infants with Type 1 spinal muscular a ...	Spinal Muscular Atrophy MedDRA version: 20.1;Level: LLT;Classification code 10051203;Term: Spinal mu ...	Product Code: LMI070 INN or Proposed INN: Not established Other descriptive name: LMI070	Novartis Pharma Services AG	NULL	Not Recruiting			Female: yes Male: yes	44	Phase 1;Phase 2	United States;Hungary;Czech Republic;Poland;Belgium;Denmark;Bulgaria;Russian Federation;Netherlands; ...
8	EUCTR2014-002053-19-BE (EUCTR)	15/12/2014	04/11/2014	Clinical trial of LMI070 given by mouth to Type I SMA infant patients.	An open-label multi-part first-in-human study of oral LMI070in infants with Type 1 spinal muscular a ...	Spinal Muscular Atrophy MedDRA version: 20.1;Level: LLT;Classification code 10051203;Term: Spinal mu ...	Product Code: LMI070 INN or Proposed INN: Branaplam Other descriptive name: LMI070	Novartis Pharma Services AG	NULL	Not Recruiting			Female: yes Male: yes	44	Phase 1;Phase 2	United States;Hungary;Czech Republic;Poland;Belgium;Denmark;Bulgaria;Russian Federation;Netherlands; ...
9	EUCTR2014-002053-19-NL (EUCTR)		27/11/2014	Clinical trial of LMI070 given by mouth to Type I SMA infant patients	An open-label multi-part first-in-human study of oral LMI070in infants with Type 1 spinal muscular a ...	Spinal Muscular Atrophy;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]	Product Code: LMI070 INN or Proposed INN: LMI070	Novartis Pharma Services AG	NULL	NA			Female: yes Male: yes	22	Phase 1;Phase 2	United States;Belgium;Denmark;Germany;Netherlands;Italy
10	EUCTR2014-002053-19-PL (EUCTR)		03/01/2018	Clinical trial of LMI070 given by mouth to Type I SMA infant patients.	An open-label multi-part first-in-human study of oral LMI070in infants with Type 1 spinal muscular a ...	Spinal Muscular Atrophy MedDRA version: 20.1;Level: LLT;Classification code 10051203;Term: Spinal mu ...	Product Code: LMI070 INN or Proposed INN: Branaplam Other descriptive name: LMI070	Novartis Pharma Services AG	NULL	NA			Female: yes Male: yes	44	Phase 1;Phase 2	United States;Hungary;Czech Republic;Belgium;Poland;Denmark;Bulgaria;Russian Federation;Netherlands; ...

First Previous1Next Last

先頭へ

8. ハンチントン病

臨床試験数 : 229 / 薬物数 : 193 - (DrugBank : 60) / 標的遺伝子数 : 84 - 標的パスウェイ数 : 158

diseases per page:

Showing 1 to 7 of 7 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2020-000105-92-LT (EUCTR)	02/03/2022	28/10/2021	A study to evaluate the safety, tolerability and efficacy of weekly oral doses of branaplam in patie ...	A Randomized, Double-Blind, Placebo-Controlled Dose Range Finding Study with Open-Label Extension to ...	Huntington's disease MedDRA version: 20.0;Level: PT;Classification code 10070668;Term: Huntington's ...	Product Name: branaplam Product Code: LMI070 INN or Proposed INN: BRANAPLAM	Novartis Pharma AG	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	75	Phase 2	France;United States;Hungary;Canada;Spain;Belgium;Lithuania;Russian Federation;Germany;United Kingdo ...
2	NCT05111249 (ClinicalTrials.gov)	December 8, 2021	15/10/2021	A Dose Range Finding Study With Open-Label Extension to Evaluate the Safety of Oral LMI070/Branaplam ...	A Randomized, Double-Blind, Placebo-Controlled Dose Range Finding Study With Open-Label Extension to ...	Early Manifest Huntington Disease	Drug: Branaplam;Drug: Placebo	Novartis Pharmaceuticals	NULL	Recruiting	25 Years	75 Years	All	75	Phase 2	Canada;France;Germany;Hungary;Spain
3	EUCTR2020-000105-92-IT (EUCTR)	26/11/2021	20/09/2021	A study to evaluate the safety, tolerability and efficacy of weekly oral doses of branaplam in patie ...	A Randomized, Double-Blind, Placebo-Controlled Dose Range Finding Study with Open-Label Extension to ...	Huntington's disease MedDRA version: 20.0;Level: PT;Classification code 10070668;Term: Huntington's ...	Product Name: branaplam Product Code: [LMI070] INN or Proposed INN: BRANAPLAM Product Name: branaplam Pr ...	NOVARTIS PHARMA AG	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	75	Phase 2	France;United States;Hungary;Canada;Spain;Belgium;Lithuania;Russian Federation;Germany;United Kingdo ...
4	EUCTR2020-000105-92-FR (EUCTR)	18/11/2021	03/09/2021	A study to evaluate the safety, tolerability and efficacy of weekly oral doses of branaplam in patie ...	A Randomized, Double-Blind, Placebo-Controlled Dose Range Finding Study with Open-Label Extension to ...	Huntington's disease MedDRA version: 20.0;Level: PT;Classification code 10070668;Term: Huntington's ...	Product Name: branaplam Product Code: LMI070 INN or Proposed INN: BRANAPLAM	Novartis Pharma AG	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	75	Phase 2	Spain;Belgium;Lithuania;Russian Federation;Germany;United Kingdom;Italy;United States;France;Hungary ...
5	EUCTR2020-000105-92-ES (EUCTR)	02/11/2021	26/08/2021	A study to evaluate the safety, tolerability and efficacy of weekly oral doses of branaplam in patie ...	A Randomized, Double-Blind, Placebo-Controlled Dose Range Finding Study with Open-Label Extension to ...	Huntington's disease MedDRA version: 20.0;Level: PT;Classification code 10070668;Term: Huntington's ...	Product Name: branaplam Product Code: LMI070 INN or Proposed INN: BRANAPLAM	Novartis Farmacéutica S.A.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	75	Phase 2	France;United States;Hungary;Canada;Belgium;Spain;Lithuania;Russian Federation;Germany;United Kingdo ...
6	EUCTR2020-000105-92-HU (EUCTR)	29/10/2021	24/08/2021	A study to evaluate the safety, tolerability and efficacy of weekly oral doses of branaplam in patie ...	A Randomized, Double-Blind, Placebo-Controlled Dose Range Finding Study with Open-Label Extension to ...	Huntington's disease MedDRA version: 20.0;Level: PT;Classification code 10070668;Term: Huntington's ...	Product Name: branaplam Product Code: LMI070 INN or Proposed INN: BRANAPLAM	Novartis Pharma AG	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	75	Phase 2	France;United States;Hungary;Canada;Spain;Belgium;Lithuania;Russian Federation;Germany;United Kingdo ...
7	EUCTR2020-000105-92-DE (EUCTR)	15/10/2021	18/08/2021	A study to evaluate the safety, tolerability and efficacy of weekly oral doses of branaplam in patie ...	A Randomized, Double-Blind, Placebo-Controlled Dose Range Finding Study with Open-Label Extension to ...	Huntington's disease MedDRA version: 20.0;Level: PT;Classification code 10070668;Term: Huntington's ...	Product Name: branaplam Product Code: LMI070 INN or Proposed INN: BRANAPLAM	Novartis Pharma AG	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	75	Phase 2	United States;France;Hungary;Canada;Spain;Belgium;Lithuania;Russian Federation;Germany;United Kingdo ...

First Previous1Next Last

先頭へ